Full-Time

Software Development Engineer III

Posted on 5/17/2025

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Senior

Hyderabad, Telangana, India

Category
Backend Engineering
Software QA & Testing
Software Engineering
Required Skills
Power BI
Redshift
Python
Postman
JUnit
Apache Spark
SQL
Tableau
AWS
Jenkins
Selenium
Databricks
Requirements
  • Hands-on experience with Databricks and Apache Spark for building and validating scalable data pipelines
  • Strong expertise in AWS services including S3, Glue, Athena, Redshift, and Lake Formation
  • Proficient in Python, PySpark, and SQL for developing test automation and validation logic
  • Experience validating data from various file formats such as JSON, CSV, Parquet, and Avro
  • In-depth understanding of data integration workflows including batch and real-time (streaming) pipelines
  • Strong ability to define and automate data quality checks: schema validation, null checks, duplicates, thresholds, and transformation validation
  • Experience designing modular, reusable automation frameworks for large-scale data validation
  • Skilled in integrating tests with CI/CD tools like GitHub Actions, Jenkins, or Azure DevOps
  • Familiarity with orchestration tools such as Apache Airflow, Databricks Jobs, or AWS Step Functions
  • Hands-on experience with API testing using Postman, pytest, or custom automation scripts
  • Proven track record of leading and mentoring QA/test engineering teams
  • Ability to define and own test automation strategy and roadmap for data platforms
  • Strong collaboration skills to work with engineering, product, and data teams
  • Excellent communication skills for presenting test results, quality metrics, and project health to leadership
  • Contributions to internal quality dashboards or data observability systems
  • Awareness of metadata-driven testing approaches and lineage-based validations
  • Experience working with agile Testing methodologies such as Scaled Agile
  • Familiarity with automated testing frameworks like Selenium, JUnit, TestNG, or PyTest.
Responsibilities
  • Define and drive the test automation strategy for data pipelines, ensuring alignment with enterprise data platform goals
  • Lead and mentor a team of data QA/test engineers, providing technical direction, career development, and performance feedback
  • Own delivery of automated data validation frameworks across real-time and batch data pipelines using Databricks and AWS services
  • Collaborate with data engineering, platform, and product teams to embed data quality checks and testability into pipeline design
  • Design and implement scalable validation frameworks for data ingestion, transformation, and consumption layers
  • Automate validations for multiple data formats including JSON, CSV, Parquet, and other structured/semi-structured file types during ingestion and transformation
  • Automate data testing workflows for pipelines built on Databricks/Spark, integrated with AWS services like S3, Glue, Athena, and Redshift
  • Establish reusable test components for schema validation, null checks, deduplication, threshold rules, and transformation logic
  • Integrate validation processes with CI/CD pipelines, enabling automated and event-driven testing across the development lifecycle
  • Drive the selection and adoption of tools/frameworks that improve automation, scalability, and test efficiency
  • Oversee testing of data visualizations in Tableau, Power BI, or custom dashboards, ensuring backend accuracy via UI and data-layer validations
  • Ensure accuracy of API-driven data services, managing functional and regression testing via Postman, Python, or other automation tools
  • Track test coverage, quality metrics, and defect trends, providing regular reporting to leadership and ensuring continuous improvement
  • Establishing alerting and reporting mechanisms for test failures, data anomalies, and governance violations
  • Contribute to system architecture and design discussions, bringing a strong quality and testability lens early into the development lifecycle
  • Lead test automation initiatives by implementing best practices and scalable frameworks, embedding test suites into CI/CD pipelines to enable automated, continuous validation of data workflows, catalog changes, and visualization updates
  • Mentor and guide QA engineers, fostering a collaborative, growth-oriented culture focused on continuous learning and technical excellence
  • Collaborate cross-functionally with product managers, developers, and DevOps to align quality efforts with business goals and release timelines
  • Conduct code reviews, test plan reviews, and pair-testing sessions to ensure team-level consistency and high-quality standards.
Desired Qualifications
  • Experience with data governance tools such as Apache Atlas, Collibra, or Alation
  • Understanding of DataOps methodologies and practices
  • Familiarity with monitoring/observability tools such as Datadog, Prometheus, or CloudWatch
  • Experience building or maintaining test data generators
  • Bachelor’s/Masters degree in computer science and engineering preferred.

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are derived from living organisms, to address conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's products work by utilizing biological processes to create effective treatments for patients. Unlike many competitors, Amgen emphasizes a strong commitment to research and development, reinvesting a large portion of its earnings to discover new therapies. The company's goal is to improve patient care and outcomes by providing effective therapeutic solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Amgen's investment in AI aligns with trends in biotechnology innovation.
  • Institutional investments indicate strong market confidence in Amgen's growth.
  • FTC clearance of the Horizon merger may ease future regulatory hurdles.

What critics are saying

  • Competitors' AI-driven drug discovery could outpace Amgen's traditional R&D methods.
  • FTC scrutiny of mergers may complicate Amgen's future growth strategy.
  • Advancements in quantum technologies could pose a competitive threat to Amgen.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline of potential new therapies in development.
  • Amgen's acquisition of Horizon Therapeutics enhances its rare disease portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.

BioSpace
Sep 19th, 2023
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans

The consent agreement struck between the FTC and Amgen and Horizon Therapeutics could have significant implications for ongoing and future M&A challenges, experts told BioSpace.